Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Protein Expression Systems Market Report 2015: Current Landscape and Future Opportunities


News provided by

Research and Markets

13 Oct, 2015, 09:10 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, Oct. 12, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/4xvfkb/protein) has announced the addition of the "Protein Expression Systems Market: Current Landscape and Future Opportunities" report to their offering.

The biologics market is considered to be worth over USD 200 billion and has an increasing number of therapeutically relevant protein based molecules in the pipeline.

Continue Reading
This image opens in the lightbox
Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

The Protein Expression Systems Market: Current Landscape and Future Opportunities report provides an extensive study of the various expression systems commercially available for the purpose of expressing the desired proteins. Selecting an effective and reliable expression system is one of the pre-requisites for pharma companies before they start proof of concept studies for biological molecules. It is well known that a particular expression system is not suitable to express every kind of protein. As such, there are several different types of platforms available to meet the growing demand.

With an extensive pipeline of biologic drugs, protein expression systems are likely to continue to garner significant attention from the biopharmaceutical industry. The report covers various aspects such as key features of these systems, associated products, licensing and services portfolio. We have also covered specific details on CMOs manufacturing biopharmaceutical products highlighting their capabilities, geographical location, scale of operation, type of biologics being manufactured and expression systems being used.

In addition, the report highlights the future growth prospects with respect to manufacturing biological molecules. The report has analyzed the overall biologics pipeline and provided specific details on some important classes such as antibody drug conjugates (ADCs) and bispecific antibodies. In addition, the emerging opportunity presented by the ongoing development of biosimilars has been highlighted. For the purposes of the study, important stakeholders were interviewed to solicit their opinions around the upcoming opportunities and challenges which must be considered for a more inclusive growth. Examples of companies interviewed include Research Corporation Technologies, iBio and Jena Bioscience.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Expression Systems: Key Features and Products

6. Company Profiles

7. CMO Services

8. Opportunity Analysis

9. SWOT Analysis

10. Interview Transcripts

11. Conclusion

12. Appendix 1: Tabulated Data

13. Appendix 2: List of Companies and Organizations

- 3P Biopharmaceuticals

- 5 PRIME

- AAIPharma Services

- AbbVie

- AbGenomics

- Abnova

- AdAlta

- ADC Therapeutics

- Aeras

- Affinicon

- Affinity Life Sciences

- Agilent Technologies

- Ajinomoto Althea

- Aldevron

- Allele Biotechnology

- Alliance Medical Products (Siegfried)

- Alpax Pharmaceuticals

- Ambrx

- AMEGA Biotech

- AMYRA Biotech

- Apotex Fermentation

- Aragen Bioscience

- Artes Biotechnology

- Asahi Glass Co.

- Astellas

- AthenaES

- AutekBio

- Avecia

- Avesta Biotherapeutics and Research

- Avid Bioservices

- Batavia Bioservices

- Bavarian Nordic

- Baxter BioPharma Solutions

- Bayer Healthcare

- BD Biosciences

- Bharat Biotech

- BIBITEC

- Binex Co.

- Bio Elpida

- BioCision

- Bio-Concept

- BioConnection

- BioConvergence

- BioGenomics

- BioGrammatics

- Bioinformatics

- BioIngenium

- BioMARC

- Biomay

- BIOMEVA

- Bioneer

- Frederick National Laboratory for Cancer Research (FNLCR)

- BioPharmaceuticals Australia

- Bio-Rad Laboratories

- BioReliance

- BioSavita

- BioSynergy

- Biotechnique

- Biotechpharma

- Biotest

- BioVectra

- Biovest International

- Biovian

- Biovolutions

- BioXcellence (Boehringer Ingelheim)

- Bristol Myers Squibb

- BroadOak Capital Partners

- Cantab Biopharmaceuticals

- Catalent

- Catalyst biosciences

- Cellca

- Celldex Therapeutics

- CellFree Sciences

- Celgene

- Celonic

- Center for Biocatalysis and Bioprocessing, The University of Iowa

- Cerbios-Pharma

- CEVEC Pharmaceuticals

- ChemPartner

- Cilian

- Clontech (a Takara Bio Company)

- CMC Biologics

- Cobra Biologics

- Cognate BioServices

- Concord Biotech

- Cook Pharmica

- Creative Biolabs

- Crucell

- Cytovance Biologics

- Dalton Pharma Services

- Development Center for Biotechnology, Taiwan

- DisperSol technologies

- DM BIO DONG-A meiji

- Dow Pharma

- Dyadic International

- Emergent BioSolutions

- Enteris BioPharma

- Esperance Pharmaceuticals

- EUCODIS Bioscience

- Eurogentec

- Florida Biologix

- FormATECH

- Formation Biologics

- FUJIFILM Diosynth Biotechnologies

- Fujirebio Europe

- Gala Biotech (Catalent subsidiary)

- GeneCopoeia

- Geneva Biotech

- Genhelix (mAbxience group)

- Genmab

- GlaxoSmithKline Biopharmaceuticals

- Glide Pharma

- Glycotope Group

- Gold Standard Diagnostics

- Goodwin Biotechnology

- Grand River Aseptic Manufacturing

- GREENOVATION

- GTP Technology

- HALIX

- Hisun Pharmaceuticals USA

- Hong Kong Institute of Biotechnology

- Hospira One 2 One

- iBIO

- IDT Biologika

- Inno Biologics

- Innovent Biologics

- Intas Pharmaceuticals

- Integrity Bio

- Intrexon

- Irvine Pharmaceutical Services

- Jena Bioscience

- Jenrin Discovery

- KABS Pharmaceutic Services

- Kairos Therapeutics

- KBI BioPharma

- Kemwell Biopharma

- Kentucky BioProcessing

- Lampire Biological Laboratories

- Leinco Technologies

- LFB Biomanufacturing

- Life Technologies

- LifeSensors

- Lonza

- Lucigen

- Lyophilization Services of New England.

- Mabion

- Maine Biotechnology Services

- MassBiologics

- MBI International

- Medicago

- Memorial Sloan-Kettering Cancer centre

- Menarini Biotech

- Merck KGaA

- Merck Millipore

- Merck Serono

- Meridian Life Science

- Miltenyi Biotec

- MoBiTec

- Mycenax Biotech

- Neuland Laboratories

- New England Biolabs

- Nextar Chempharma Solutions

- Norwegian Institute of Public Health

- Nova Laboratories

- Novasep

- Novozymes

- OctoPlus

- Omnia Biologics

- Orflo Technologies

- OsoBio (AMRI)

- Oxford Expression Technologies

- PacificGMP

- PATH

- Paragon Bioservices

- Patheon (unit of DPx Holdings)

- Pfizer CentreSource

- PharmaSynth

- Pharmedartis

- Phyton Biotech

- Piramal Pharma Solutions

- Plant BioScience

- Plasmid Factory

- Polymun Scientific

- Premas Biotech

- ProBioGen

- ProteoNic

- Progenitor Cell Therapy

- ProMab Biotechnologies

- Promega Corporation

- Protalix Biotherapeutics

- Provantage Biodevelopment Center

- PX'Therapeutics

- PYRAMID Laboratories

- QuaDPharma

- Reliance Life Sciences

- Rentschler Biotechnologie

- Research Corporation Technologies

- Rhein Biotech

- Richter-Helm BioTec

- RiNA

- SAFC

- Samsung BioLogics

- Sandoz

- Sanofi Pasteur

- Sanofi CEPiA

- Sanquin Pharmaceutical Services

- Scarab Genomics

- Scil Proteins

- Shasun

- SICOR Biotech (Teva)

- Sigma-Aldrich Corporation

- Sinocelltech

- Statens Serum Institut

- Strides Arcolab

- Sutro Biopharma

- Symbiosis Pharmaceutical Services

- SynCo Bio Partners

- Syngene (Subsidiary of Biocon)

- Synthon

- Sypharma

- Tetragenetics

- Teva Pharmaceuticals

- Therapure Biopharma

- Thermo Fisher Scientific

- Toyobo Biologics

- Trenzyme

- University of California, San Francisco (UCSF)

- University of Nebraska

- Valneva

- Vetter Pharma International

- VGXI

- Vibalogics

- Vista Biologicals Corp.

- Vivalis SA

- VTU Technology

- Wacker Biotech

- Waisman Biomanufacturing

- Wockhardt

- WuXi AppTec

- Xbrane Bioscience

- Xcelience

- Zhejiang Medicine Co.

- Zymeworks

For more information visit http://www.researchandmarkets.com/research/4xvfkb/protein

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.